Myoscreen™, a drug discovery platform for disease modeling and the screening of compounds restoring muscle health

被引：0
|
作者：
Flaender, M. [1 ]
Young, J. [1 ]
Duchemin-Pelletier, E. [1 ]
Lorintiu, O. [1 ]
Poydenot, P. [1 ]
机构：
[1] Cytoo, Grenoble, France
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.186
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.130
引用
收藏
页码：S86 / S86
页数：1
相关论文
共 50 条
  • [1] MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery
    Young, Joanne
    Margaron, Yoran
    Fernandes, Mathieu
    Duchemin-Pelletier, Eve
    Michaud, Joris
    Flaender, Melanie
    Lorintiu, Oana
    Degot, Sebastien
    Poydenot, Pauline
    [J]. SLAS DISCOVERY, 2018, 23 (08) : 790 - 806
  • [2] Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery
    LaBarbera, Kelsie Mozzoni
    Limegrover, Colleen
    Rehak, Courtney
    Yurko, Raymond
    Izzo, Nicholas John
    Knezovich, Nicole
    Watto, Emily
    Waybright, Lora
    Catalano, Susan M.
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2021, 358
  • [3] MyoScreen, a robust muscle-based assay platform validated for screening pharmacologicals against myotonic dystrophy
    Flaender, M.
    Young, J.
    Duchemin-Pelletier, E.
    Lorintiu, O.
    Compere, L.
    Champetier, T.
    Ventre, E.
    [J]. NEUROMUSCULAR DISORDERS, 2021, 31 : S120 - S121
  • [4] iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
    Corbett, James L.
    Duncan, Stephen A.
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [5] Skeletal muscle-on-a-chip in microgravity as a platform for regeneration modeling and drug screening
    Kim, Soochi
    Ayan, Bugra
    Shayan, Mahdis
    Rando, Thomas A.
    Huang, Ngan F.
    [J]. STEM CELL REPORTS, 2024, 19 (08): : 1061 - 1073
  • [6] Engineered Muscle Tissues for Disease Modeling and Drug Screening Applications
    Mohammadi, Mohammad Hossein
    Obregon, Raquel
    Ahadian, Samad
    Ramon-Azcon, Javier
    Radisic, Milica
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (20) : 2991 - 3004
  • [7] Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
    Ebert, Antje D.
    Liang, Ping
    Wu, Joseph C.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (04) : 408 - 416
  • [8] MyoScreen-A High-Content-Based Discovery Platform to Model Key Metabolic Processes in Human Skeletal Muscle
    Morozzi, Giulio
    Zablocki, Aniela
    Martin-Tissier, Antoine
    Travard, Lauriane
    Massera, Celine
    Flaender, Melanie
    Fargier, Guillaume
    Lorintiu, Oana
    Ventre, Erwann
    Young, Joanne
    Autier, Valerie
    Selig, Luc
    [J]. DIABETES, 2024, 73
  • [9] iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies
    Ortiz-Vitali, Jose L.
    Darabi, Radbod
    [J]. CELLS, 2019, 8 (01)
  • [10] Tissue-engineered heart chambers as a platform technology for drug discovery and disease modeling
    Mousavi, Ali
    Stefanek, Evan
    Jafari, Arman
    Ajji, Zineb
    Naghieh, Saman
    Akbari, Mohsen
    Savoji, Houman
    [J]. BIOMATERIALS ADVANCES, 2022, 138
12345